- Home
- ETON vs ATNI Comparison
ETON vs ATNI Comparison
Compare ETON & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- ATNI
- Stock Information
- Founded
- ETON 2017
- ATNI 1987
- Country
- ETON United States
- ATNI United States
- Employees
- ETON N/A
- ATNI N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- ATNI Telecommunications Equipment
- Sector
- ETON Health Care
- ATNI Telecommunications
- Exchange
- ETON Nasdaq
- ATNI Nasdaq
- Market Cap
- ETON 428.5M
- ATNI 267.1M
- IPO Year
- ETON 2018
- ATNI 1991
- Fundamental
- Price
- ETON $17.33
- ATNI $15.56
- Analyst Decision
- ETON Strong Buy
- ATNI Strong Buy
- Analyst Count
- ETON 3
- ATNI 1
- Target Price
- ETON $27.67
- ATNI $30.00
- AVG Volume (30 Days)
- ETON 221.4K
- ATNI 57.6K
- Earning Date
- ETON 05-13-2025
- ATNI 04-30-2025
- Dividend Yield
- ETON N/A
- ATNI 6.03%
- EPS Growth
- ETON N/A
- ATNI N/A
- EPS
- ETON N/A
- ATNI N/A
- Revenue
- ETON $39,011,000.00
- ATNI $721,575,000.00
- Revenue This Year
- ETON $92.33
- ATNI $1.85
- Revenue Next Year
- ETON $52.62
- ATNI $1.51
- P/E Ratio
- ETON N/A
- ATNI N/A
- Revenue Growth
- ETON 23.29
- ATNI N/A
- 52 Week Low
- ETON $3.18
- ATNI $14.63
- 52 Week High
- ETON $18.41
- ATNI $33.72
- Technical
- Relative Strength Index (RSI)
- ETON 68.29
- ATNI 36.53
- Support Level
- ETON $16.43
- ATNI $14.63
- Resistance Level
- ETON $17.49
- ATNI $16.80
- Average True Range (ATR)
- ETON 0.88
- ATNI 0.91
- MACD
- ETON 0.19
- ATNI -0.09
- Stochastic Oscillator
- ETON 92.78
- ATNI 25.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.